Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1)
Open Access
- 10 November 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 53 (2), 378-388
- https://doi.org/10.1007/s00125-009-1529-y
Abstract
The role of TNF-α in impaired wound healing in diabetes was examined by focusing on fibroblasts. Small excisional wounds were created in the db/db mice model of type 2 diabetes and normoglycaemic littermates, and in a streptozotocin-induced type 1 diabetes mouse model and control mice. Fibroblast apoptosis was measured by the TUNEL assay, proliferation by detection of proliferating cell nuclear antigen, and forkhead box O1 (FOXO1) activity by DNA binding and nuclear translocation. TNF-α was specifically inhibited by pegsunercept. Diabetic wounds had increased TNF-α, fibroblast apoptosis, caspase-3/7 activity and activation of the pro-apoptotic transcription factor FOXO1, and decreased proliferating cell nuclear antigen positive fibroblasts (p < 0.05). TNF-α inhibition improved healing in the diabetic mice and increased fibroblast density. This may be explained by a decrease in fibroblast apoptosis and increased proliferation when TNF-α was blocked (p < 0.05). Although decreased fibroblast proliferation and enhanced FOXO1 activity were investigated in type 2 diabetes, they may also be implicated in type 1 diabetes. In vitro, TNF-α enhanced mRNA levels of gene sets related to apoptosis and Akt and p53 but not mitochondrial or cell-cycle pathways. FOXO1 small interfering RNA reduced gene sets that regulate apoptosis, Akt, mitochondrial and cell-cycle pathways. TNF-α also increased genes involved in inflammation, cytokine, Toll-like receptor and nuclear factor-kB pathways, which were significantly reduced by FOXO1 knockdown. These studies indicate that TNF-α dysregulation in diabetic wounds impairs healing, which may involve enhanced fibroblast apoptosis and decreased proliferation. In vitro, TNF-α induced gene sets through FOXO1 that regulate a number of pathways that could influence inflammation and apoptosis.This publication has 50 references indexed in Scilit:
- Diabetes-Enhanced Tumor Necrosis Factor-α Production Promotes Apoptosis and the Loss of Retinal Microvascular Cells in Type 1 and Type 2 Models of Diabetic RetinopathyThe American Journal of Pathology, 2008
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast ActivityJournal of Bone and Mineral Research, 2007
- CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA DamageScience, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- FOXO1 Functions as a Master Switch That Regulates Gene Expression Necessary for Tumor Necrosis Factor-induced Fibroblast ApoptosisOnline Journal of Public Health Informatics, 2005
- Biologic Therapy for Inflammatory Bowel DiseaseDrugs, 2005
- Accelerated wound healing in tumor necrosis factor receptor p55‐deficient mice with reduced leukocyte infiltrationThe FASEB Journal, 2002
- Cutaneous Wound HealingThe New England Journal of Medicine, 1999
- Tumor Necrosis Factor Alpha Inhibits Wound Healing in the RatEuropean Surgical Research, 1991